factual

Suvorexant as an Epic Discovery-Driven Drug Story

The insomnia drug suvorexant exemplifies genuine discovery-driven development: decades of academic research uncovered orexin, a brain chemical that keeps you awake (opposite of melatonin), prompting pharmaceutical companies to hypothesize some insomnia stems from excess orexin binding, screen two million compounds to find a receptor blocker, and run clinical trials costing around a billion dollars over another decade to produce the drug.

factualpending

Speaker

Nicole Rust

Evidence Quote

“you have decades of academic research, another decade in the pharmaceutical industry, and then you get a drug. It's just a really epic tale of how many people and hours went into the development of that.”

Source

317 | Nicole Rust on Why Neuroscience Hasn't Solved Brain Disorders— Sean Carroll's Mindscape
Created: 6/13/2026, 12:22:22 AM

Your notes

Loading notes...